Victory Capital Management Inc Macrogenics Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$9.77 - $21.47 $329,737 - $724,612	33,750 New	33,750 $496,000
Q1 2023 May 02, 2023	BUY	$4.82 - $7.24 $644,675 - $968,350	133,750 New	133,750 $958,000
Q4 2021 Feb 07, 2022	SELL	$15.91 - $21.88 $31.3 Million - $43 Million	-1,965,101 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$19.74 - $28.7 $6.23 Million - $9.06 Million	315,629 Added 19.14%	1,965,101 $41.1 Million
Q2 2021 Aug 03, 2021	BUY	$20.49 - $35.63 $8.25 Million - $14.4 Million	402,803 Added 32.31%	1,649,472 $44.3 Million
Q1 2021 May 04, 2021	BUY	$18.99 - $33.2 $22.4 Million - $39.2 Million	1,179,339 Added 1751.58%	1,246,669 $39.7 Million
Q4 2020 Feb 01, 2021	SELL	$19.41 - $26.0 $243,595 - $326,300	-12,550 Reduced 15.71%	67,330 $1.54 Million
Q3 2020 Nov 09, 2020	SELL	$24.69 - $31.6 $71,601 - $91,640	-2,900 Reduced 3.5%	79,880 $2.01 Million
Q2 2020 Aug 07, 2020	SELL	$5.2 - $29.12 $1.17 Million - $6.56 Million	-225,155 Reduced 73.12%	82,780 $2.31 Million
Q1 2020 May 04, 2020	SELL	$4.28 - $12.11 $67,294 - $190,405	-15,723 Reduced 4.86%	307,935 $1.79 Million
Q4 2019 Feb 06, 2020	BUY	$7.95 - $12.27 $48,979 - $75,595	6,161 Added 1.94%	323,658 $3.52 Million
Q4 2019 Feb 04, 2020	SELL	$7.95 - $12.27 $73,791 - $113,890	-9,282 Reduced 2.84%	317,497 $2.94 Million
Q3 2019 Nov 12, 2019	BUY	$12.44 - $17.48 $2.74 Million - $3.85 Million	220,179 Added 206.55%	326,779 $4.17 Million
Q2 2019 Aug 15, 2019	BUY	$14.51 - $19.71 $53,251 - $72,335	3,670 Added 3.57%	106,600 $1.81 Million
Q1 2019 May 03, 2019	SELL	$11.11 - $25.6 $11,554 - $26,624	-1,040 Reduced 1.0%	102,930 $1.85 Million
Q4 2018 Feb 05, 2019	SELL	$11.75 - $21.42 $21,150 - $38,556	-1,800 Reduced 1.7%	103,970 $1.32 Million
Q3 2018 Nov 01, 2018	SELL	$19.26 - $23.46 $1.18 Million - $1.44 Million	-61,400 Reduced 36.73%	105,770 $2.27 Million
Q2 2018 Aug 02, 2018	SELL	$19.78 - $24.67 $186,525 - $232,638	-9,430 Reduced 5.34%	167,170 $3.45 Million
Q1 2018 May 04, 2018	BUY	$18.89 - $32.46 $3.34 Million - $5.73 Million	176,600 New	176,600 $4.44 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account